Leander, Peter <br/><br/>
Orally administered manganese with and without ascorbic acid as a liver-specific contrast agent and bowel marker for magnetic resonance imaging: phase I clinical trial assessing efficacy and safety.  [electronic resource] 

 -  Investigative radiology  Sep 2010 
 - 559-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-0210 
<br/><br/><label>Standard No.: </label>10.1097/RLI.0b013e3181e960ab  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abdomen--diagnostic imaging<br/>Administration, Oral<br/>Adult<br/>Antioxidants--administration & dosage<br/>Ascorbic Acid--administration & dosage<br/>Biomarkers<br/>Contrast Media--administration & dosage<br/>Cross-Over Studies<br/>Drug Therapy, Combination<br/>Humans<br/>Intestine, Large--diagnostic imaging<br/>Liver--diagnostic imaging<br/>Male<br/>Manganese--administration & dosage<br/>Radionuclide Imaging<br/>Statistics as Topic<br/>Time Factors<br/>Trace Elements--administration & dosage